Metformin may decrease of lung cancer among nonsmokers with diabetes
the ONA take:
According to a new study published in the journal Cancer Prevention Research, researchers have found that nonsmokers who took metformin to treat their type 2 diabetes had a decreased risk for developing lung cancer compared with those who did not take antidiabetic drug.
For the retrospective cohort study, researchers analyzed data from health-related surveys completed by 47,351 patients with diabetes between 1994 and 1996. By looking at electronic pharmacy records, researchers found that 46% of those had filled at least two prescriptions for metformin within a 6-month period, defined as ever-users.
Results showed that during the 15-year follow-up, 747 patients developed lung cancer, 80 of whom were nonsmokers while 203 were current smokers. Researchers found no association between metformin use and a decreased overall lung cancer risk, but they observed a 43% risk reduction among patients with diabetes who had never smoked.
Although not statistically significant, researchers found that nonsmokers who took metformin for at least 5 years had a 52% decreased risk for developing lung cancer.
The findings suggest that metformin may decrease the risk of lung cancer in nonsmokers, but large, prospective studies are warranted to determine if metformin can decrease the risk of developing certain cancers.
Nonsmokers who took metformin to treat their type 2 diabetes had a decreased risk for developing lung cancer.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|